This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3fq9
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 3fq9 is ON HOLD | + | The entry 3fq9 is ON HOLD until Paper Publication |
Authors: Zhao, M., Wan, Z.L., Whittaker, L., Xu, B., Phillips, N., Katsoyannis, P., Whittaker, J., Weiss, M.A. | Authors: Zhao, M., Wan, Z.L., Whittaker, L., Xu, B., Phillips, N., Katsoyannis, P., Whittaker, J., Weiss, M.A. | ||
| Line 7: | Line 7: | ||
Description: Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications | Description: Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul 1 08:53:56 2009'' |
Revision as of 05:53, 1 July 2009
Unreleased structure
The entry 3fq9 is ON HOLD until Paper Publication
Authors: Zhao, M., Wan, Z.L., Whittaker, L., Xu, B., Phillips, N., Katsoyannis, P., Whittaker, J., Weiss, M.A.
Description: Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications
Page seeded by OCA on Wed Jul 1 08:53:56 2009
